Search Results 801-810 of 13454 for Systemic Autoinflammatory Diseases

  1. Joint Hypermobility, Autonomic Dysfunction, Gastrointestinal Dysmotility – Autoimmune Type Registry - Mayo Clinic

    Patients with a suspected motility disorder, dysautonomia, rheumatic or autoimmune disease. Exclusion Criteria: Inability to comply with study procedures ...

  2. Neurology - Clinical trials - Mayo Clinic

    Diseases & conditions · Find a doctor. Care at Mayo Clinic. Patient-Centered Care ... systemic therapy; (2) if patient is already engaged in an ongoing cyclical ...

  3. DALY II USA/ MB-CART2019.1 For DLBCL - Mayo Clinic

    Severely immunocompromised subjects e.g., due to current treatment of non-neurologic autoimmune disease (e.g., Crohn's disease, rheumatoid arthritis, systemic ...

  4. Rafid Mustafa, M.D. - Doctors and Medical Staff - Mayo Clinic

    Mustafa's academic work includes research in neurologic complications of systemic disease, quality improvement, patient safety, and medical education.

  5. Publications - Konstantinos A. Papadakis, M.D. - Mayo Clinic

    Mechanisms of Disease: Inflammatory Bowel Diseases. Mayo Clin Proc. 2019 Jan; 94 (1):155-165. View PubMed; Ramos GP, Stroh G, Al-Bawardy B, Faubion WA ...

  6. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    Long-lasting diarrhea and belly pain could be caused by inflammatory bowel disease, also called IBD. Learn about IBD causes, diagnosis and treatment.

  7. Meet Our Fellows - Rheumatology Fellowship (Florida) - Mayo Clinic College of Medicine & Science

    Clinical interests: Systemic scleroderma, sarcoidosis, inflammatory myopathies, vasculitis. Research interests: Stem cell therapy in autoimmune disease ...

  8. Endocarditis - Symptoms and causes - Mayo Clinic

    Diseases & conditions · Find a doctor. Care at Mayo ... Temporal trends of infective endocarditis in North America from 2000 to 2017 — A systematic review.

  9. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  10. A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer - Mayo Clinic

    Ongoing or recent evidence of significant autoimmune disease that required treatment with systemic immunosuppressive treatments, which may suggest a risk of ...